Clinical evaluation of the topical application of Magnolignan® (5,5'-dipropyl-biphenyl-2,2'-diol) for hyperpigmentation on the face

Nishinihon Journal of Dermatology

Volumn 68, Issue 3, 2006, Pages 293-298

  Takeda, Katsuyuki ^a   Arase, Seiji ^a   Sagawa, Yoshiaki ^b   Shikata, Yuko ^c   Okada, Hiroyuki ^d   Watanabe, Shinichi ^e   Yokota, Tomohiro ^f   Ikemoto, Takeshi ^f   Kakishima, Hiroshi ^f   Matsuo, Toru ^f  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Sagawa Clinic   (Japan)

^c Shikata Dermatological Clinic   (Japan)

^d Okada Clinic of Dermatology   (Japan)

^e TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f KANEBO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5,5' DIPROPYL BIPHENYL 2,2' DIOL; BIPHENYL DERIVATIVE; DERMATOLOGICAL AGENT; MAGNOLIGNAN; UNCLASSIFIED DRUG;

ARTICLE; CHLOASMA; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; DRUG SAFETY; FACE DISORDER; FEMALE; HUMAN; HYPERPIGMENTATION; LENTIGO; MAJOR CLINICAL STUDY; QUESTIONNAIRE; SKIN DEFECT; SKIN MANIFESTATION;

EID: 33745746283     PISSN: 03869784     EISSN: None     Source Type: Journal    
DOI: 10.2336/nishinihonhifu.68.293     Document Type: Article

References (8)